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Abstract
Background: This study sought to establish the preferences of people with Rheumatoid Arthritis (RA) about the
best outcome measure for a health and fitness intervention randomised controlled trial (RCT). The results of this
study were used to inform the choice of the trial primary and secondary outcome measure.
Methods: A discrete choice experiment (DCE) was used to assess people’s preferences regarding a number of
outcomes (foot and ankle pain, fatigue, mobility, ability to perform daily activities, choice of footwear) as well as
different schedules and frequency of delivery for the health and fitness intervention. The outcomes were chosen
based on literature review, clinician recommendation and patients’ focus groups. The DCE was constructed in SAS
software using the D-efficiency criteria. It compared hypothetical scenarios with varying levels of outcomes severity
and intervention schedule. Preference weights were estimated using appropriate econometric models. The partial
log-likelihood method was used to assess the attribute importance.
Results: One hundred people with RA completed 18 choice sets. Overall, people selected foot and ankle pain as
the most important outcome, with mobility being nearly as important. There was no evidence of differential
preference between intervention schedules or frequency of delivery.
Conclusions: Foot and ankle pain can be considered the patient choice for primary outcome of an RCT
relating to a health and fitness intervention. This study demonstrated that, by using the DCE method, it is
possible to incorporate patients’ preferences at the design stage of a RCT. This approach ensures patient
involvement at early stages of health care design.
Keywords: Rheumatoid arthritis, Discrete choice experiment, Choice of outcome measure, Randomized clinical
trial
Background
Rheumatoid arthritis (RA) is a systemic, disabling disease
which has a prevalence of 0.44% for men and 1.16% for
women in the UK [1], equating to around 400,000 adults
having the condition in 2006 [2]. Approximately 90% of
people with RA eventually develop symptoms related to
the foot or ankle [3]. The occurrence of RA in the feet can
reduce mobility, place restrictions on daily life and cause
pain for patients, hence affecting quality of life [4]. In
addition, those with impaired walking ability due to RA of
the feet are also at increased risk of falling and hence, fall-
related injuries such as fractures may occur. The feet are
affected early in the disease course of RA, with pain or
damage leading to altered gait [5, 6].
Currently there is no treatment offered which specifically
aims to help maintain or improve walking ability for people
with RA of the foot or ankle. Benefits have been shown for
gait rehabilitation strategies (i.e. a range of techniques to
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improve walking) in people who have other conditions
where their walking is affected [7, 8]. However, there have
been no randomised controlledtrials (RCTs) conducted in
this area to assess it fully. It would therefore be valuable to
design and undertake a RCT in order to assess the
effectiveness of a health and fitness intervention intended
to facilitate gait rehabilitation in people with RA of the foot
or ankle. The health and fitness intervention will adopt the
nature of an existing programme, ESCAPE [9], which
enables self-management and coping with arthritic pain
using exercise, and is widely used for people with chronic
joint pain.
A crucial element for the conduct of a rigorous study
is the collection of the most appropriate outcome on as
many trial participants as possible [10]. The decision as
to which outcome(s) should constitute the primary out-
come(s) of an RCT - and which are secondary out-
comes- is made by the study investigators, with clinical
advice where required (e.g. through Delphi panels of cli-
nicians to reach consensus on the most appropriate out-
come). This choice is often driven by what has been
used in previous studies or through a literature review
and what clinicians perceive as being most clinically
relevant to patients, once the relationship between the
intervention component and the outcome measure, to-
gether with the theories concerning mode-of-action of
the intervention have been established. More recently,
and in accordance with guidance from the patient group
INVOLVE [11], the views of patients are being included
in the choice of outcome measurements. This approach
ensures the patient involvement in the health care deci-
sion making process, which is in line with governments
initiatives in many health care systems [12]. For greater
benefits, both in financial and clinical outcomes terms,
the involvement of the patients is thought to be
pertinent not only at the care level, but also at the re-
search and design level [13]. This is clearly defined in
the aims of the National Health System (NHS) in the
UK [14] where the patients are invited to be involved in
the co-design, co-commissioning and co-production of
health care.
This approach is potentially very important as a pa-
tient perspective can not only identify key outcomes but
can be used to weight or sequence key outcomes in
order of their perceived importance. In this paper we
demonstrate a method – the Discrete Choice Experi-
ment (DCE) - of identifying and then prioritising the key
outcomes that are important to patients, once clinically
relevant outcomes have been identified and mechanisms
of change are known. This enables the trialists to design
research around the primary outcome supported by the
patient group of interest and include relevant secondary
outcome measures. The primary outcome measure for
clinical trials is, arguably, not directly or solely decided
by patient preferences. Some outcome measures, such as
survival, might be straight forward to choose but often
there are trade-offs between a treatments effect, its in-
tensity and modality and patients are probably best
placed to make a judgement as to the priority of these
different aspects. The DCE can combine the use of
qualitative methods (i.e. interviewing patients as to their
choice of attributes) with a quantitative methodology to
prioritise these attributes. As well as aiding the identifi-
cation of key outcomes, a DCE can also help researchers
refine their choice of intervention by asking potential
participants to prioritise the various treatment options
so that when there are mutually exclusive choices (e.g.
group versus one-to-one therapy) the DCE can inform
treatment construction.
A DCE is a quantitative method for eliciting prefer-
ences regarding alternative scenarios or options. Partici-
pants are presented with alternative hypothetical
scenarios and are asked to indicate their most preferred
option, with each option involving several attributes
(outcomes) with different levels. DCEs have been com-
monly used in the field of health economics to address a
wide range of policy questions [15]. By conducting a
DCE at an early stage in the RCT design, it can help en-
sure that the primary outcome of the trial is relevant to
the patient, in this instance those with a diagnosis of
RA. The aim of this study was to use a DCE in order to
assess the relative importance of different outcomes, as
well as the nature and schedule of the intervention, with
the findings helping to guide the design of an RCT in
this area.
Methods
Outcomes identification
The Leeds Foot Impact Scale (LFIS) [16] served as the ini-
tial tool for the identification of the outcomes related to
foot and ankle RA. LFIS is a quantitative measure of foot
impacts associated with RA. It includes 2 subscales, and
51-items covering the domains of impairments/shoes and
activities/participation. LFIS is considered a reliable,
disease-specific scale to measure the outcome of interven-
tions for studies in the foot and ankle RA field [16]. A lit-
erature review was then conducted with the aim to
supplement and support the choice of the attributes from
the LFIS. It sought to find the most frequently reported
outcomes in RA of foot and ankle patients. The review
was conducted using Pubmed and Embase databases,
using broad search terms like “rheumatoid arthritis” and
“patient reported outcomes”.
The identified outcomes were used to populate the
list of attributes to be included in the DCE. Five attri-
butes were selected that were deemed to be the most
important outcomes from patients’ and clinical per-
spectives, and reported in the literature.
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(i) Pain. Changes in pain have been identified as the
most important reported outcome from a patient’s
perspective both clinically and in RA trials [17–20].
Furthermore, the inclusion of pain as one of the
seven core set of outcomes of disease activity as
identified by both the American College of
Rheumatology (ACR) [21] and European League
against Rheumatism (EULAR) [22] emphasises its
importance from a clinician’s perspective. Using a
nominal group technique (n = 26), Sanderson et al.
[17] refined a previously established list of 63
important patient reported outcomes [23] and
identified reducing pain as the top priority outcome
ahead of limiting joint damage, reducing fatigue,
improving ability to perform daily living activities
and mobility. Similarly, studies by Gossec et al. [18],
Heiberg et al. [19] and ten Klooster et al. [20] all
identified changes in pain as the predominant
patient reported outcome.
(ii)Fatigue. Fatigue has been reported to be an under
reported attribute in RA [24] however in 2007, as a
result of a patient focus group discussions, it was
recommended by Outcome Measures in
Rheumatology (OMERACT [25]) that measurement
of fatigue was included alongside the 7 items identified
in the ACR core set [26]. This recommendation was
subsequently supported by both ACR and EULAR in
2008 [27]. A number of qualitative studies have
identified fatigue as one of the most important patient
perceived outcomes [17, 18, 26, 28]. Both Sanderson
et al. [17] and Gossec et al. [18] reported reduced
fatigue as the third most important patient perceived
outcome behind pain and either joint damage [17] or
physical disability [18].
(iii)Mobility. Given the development of foot and ankle RA
is associated with decreased walking speed, increased
periods of double stance and reduced joint range of
motion [29], changes in mobility represents an
important patient reported outcome in RA patients.
Focus group interviews with Swedish RA patients (n =
25) identified increased mobility along with reduced
pain, stiffness and fatigue as important contributors to
improved physical capacity [28]. In two studies [19, 20]
using the AIMS2 questionnaire (which focuses on 12
areas of health – mobility, walking and bending, hand
and finger function, arm function, self-care, household
tasks, social activity, support from family, arthritis pain,
work, level of tension and mood) walking and bending,
and mobility were identified as being in the top five
priority areas for health improvement. Heiberg & Kvien
[19], which surveyed 1024 Norwegian RA patients,
identified walking and bending as the third preferential
area (33.3%) for health improvement, with mobility
ranked fifth (23.9%). Similarly, ten Klooster et al. [20]
reported over a 1 year period of active RA treatment
(n = 173); priorities for improvement did not vary
greatly with walking and bending (42.2%), and mobility
(32.9%) ranked as the third and fourth
preferential areas of improved health.
(iv)Ability (or lack of ) to perform activities of daily
living. Along with the mobility issues discussed
previously, the ability (or lack of) to perform activities
of daily living (e.g. work and household tasks, family
and leisure activities) is another important area
highlighted by RA as impacting on patients lives [17,
19, 28]. Qualitative studies by Sanderson et al. [17]
and Ahlmen et al. [28] both highlighted a decline in
the ability to perform everyday activities impacted on
the independence of RA patients. Furthermore, a
decline in both ability to perform activities of daily
living and mobility were identified as components that
contribute to increased functional disability [17].
(v)Choice of footwear. Although choice of footwear has
not previously been identified as a priority outcome
in RA patients, the majority of studies have focused
on RA as an overarching disease affecting the whole
body rather than focusing specific regions (e.g.
ankle/ft, hands). Rheumatoid arthritis of the ankle
and foot can result in specific limitations with the
development of joint stiffness and deformity acting
as factors that can limit the choice of suitable
footwear available to the patient [16]. Whilst
correctly fitted therapeutic footwear and orthotics
are thought to reduce pain, improve mobility and
preserve foot function [30, 31], ill-fitting or incorrect
footwear can exacerbate the symptoms [32].
Furthermore, despite the potential therapeutic
benefits of specialist footwear, a reluctance to wear
them can exist, especially in female patients, where
the appearance of the footwear is reported to poten-
tially have a negative effect on body image [33].
Restriction to footwear choice therefore represents
an important factor in foot and ankle RA patients.
One additional attribute was a “process” attribute and
was chosen to elicit patients’ preference for the schedule
of the intervention. Similar to choosing an outcome as
primary outcome of the RCT, the attribute related to the
schedule of the intervention would feed into the design
of the RCT. There were two components for this attri-
bute: whether the intervention was delivered on a one-
to-one or on a group basis, and the frequency of attend-
ance i.e. whether it was delivered once a week for
12 weeks or twice a week for 6 weeks.
All the attributes, with the exception of the schedule
of the intervention, were described as three level attri-
butes ranging from extremely bad to extremely good
states (Table 1).
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Qualitative work
In addition to the literature review, consultation with clini-
cians and stakeholder groups, through focus groups and in-
terviews, contributed to the validation and the refinement
of the list of attributes and the respective levels. Three cli-
nicians, working across primary and secondary care ser-
vices within Wessex healthcare region, were involved. The
attributes were also discussed with patients from two NHS
services who were invited by way of email to an established
patient advice group to contribute to this work. Two key
lay members were subsequently identified and had further
specific input into this work. All groups involved were
asked to generally comment on whether attributes chosen
represent the most important outcomes for patients with
foot and ankle RA. The list was finalized through an itera-
tive process of adding/removing attributes and improving
wording of the attributes and levels, and seeking consensus
amongst clinicians, patients and lay members.
Design of the experiment
The number of the attributes chosen for this DCE and the
respective levels would result in 3^5*4 = 972 profiles or sce-
narios (i.e. all possible combinations of five three-level and
one four-level attributes) and 471,906 choice pairs [i.e.
(972 × 971)/2]. A D-efficient (or D-optimal) design was
chosen to produce a manageable number of choice pairs,
yet satisfying statistical efficiency. D-Optimality character-
izes the selection of a special set of experiments which ful-
fils a given criterion. In a D-optimal design the
determinant of the covariance matrix is minimized. Hence,
there is minimum variation around the parameter esti-
mates due to minimized estimated standard errors [34, 35].
The experimental design was created in SAS software
(version 9.4) with the use of in-built macros [36]. %
mktruns macro creates the candidate alternatives and rec-
ommends possible design sizes. No prior assumptions
were made about the parameters to be estimated; hence
they were set to be zero. A number of designs with varying
number of choice sets and respective D-efficiency criter-
ion were explored with the aim of choosing the design
which provided the best compromise between statistical
efficiency and minimizing the cognitive burden to the re-
spondents, due to the length of the questionnaire. A 18-
choice set design was chosen. One choice set was repeated
to test the consistency of the responses. Only main effects
are estimated by this experimental design; inclusion of
interaction terms would have resulted in a larger number
of choice sets and lengthier questionnaire.
The choice task and data collection
A market research company, Research Now, which
maintains large panels of respondents, was employed for
Table 1 List of attributes and levels
Attributes Levels Variable name used in the model
Pain My feet are not painful when I walk
My feet are somewhat painful when I walk
My feet are extremely painful when I walk
pain_2
pain_1
Reference
Mobility
(e.g. walking, climbing stairs)
I have no problems with mobility
I have some problems with mobility
I have extreme problems with mobility
mobility_2
mobility_1
Reference
Doing everyday things / activities of daily living
(e.g. work, study, housework, family or leisure
activities)
I have no problems with doing
everyday activities
I have some problems with doing
everyday activities
I have extreme problems with doing
everyday activities
daily_activities_2
daily_activities_1 Reference
Fatigue I usually do not feel tired after walking
I usually feel moderately tired after walking
I usually feel extremely tired after walking
fatigue_2
fatigue_1
Reference
Shoes (choice of footwear) My walking ability is not affected by the
footwear I choose.
My walking ability is moderately affected
by the footwear I choose.
My walking ability is greatly affected by the footwear I choose
shoes_2
shoes_1
Reference
Health and fitness – exercise supervised by a
physiotherapist or podiatrist
To improve my walking, I will go for one-to-one
supervised exercise, twice a week for 6 weeks (1)
To improve my walking, I will go for one-to-one
supervised exercise, once
a week for 12 weeks (2)
To improve my walking, I will go for supervised
exercise as part of a group twice a week for 6 weeks. (3)
To improve my walking, I will go for
supervised exercise as part of a group once a
week for 12 weeks. (4)
health_fitness_3
health_fitness_2
health_fitness_1
Reference
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the data collection. The company recruited the respon-
dents, designed the web questionnaire based on the ex-
perimental design, and constructed the survey website.
One hundred RA patients aged 18 or over and based in
the UK were recruited to complete the survey. Symbolic
remuneration fees were given to the respondents. In
addition to completing the DCE, participants provided
information on their age, occupation and region of resi-
dence in the UK.
An information page and instruction on how to
complete the survey were provided in the opening page
of the web survey. Participants were presented with the
list of choice sets (in random order) and were asked to
choose the most preferred scenario between the two in
each choice set, not the option they felt closely
reflected their current situation. Participants were fa-
miliarized with the task by responding to two “warm-
up” choice sets.
The participant information sheet and an example
DCE choice set are provided in Fig. S1 and Fig. S2 of the
Additional file 1 respectively.
Data analysis
The analysis of the DCE data is based on the random
utility framework, where the respondent is assumed to
choose within a choice set the alternative that will maxi-
mise their utility. The utility function is specified as:
Uiq ¼ V Xiq; β
 
þ εiq ð1Þ
[15] where Uiq is the utility of the ith alternative for
the qth individual. The utility is comprised of a sys-
tematic component, V (Xiq, β) specified as a function
of the attributes of the alternatives, and a random
component εiq which captures the unmeasured vari-
ation in preferences.
Three econometric models were used for the analysis
of the DCE data based on different assumptions: a con-
ditional logit model (CLOGIT), which is considered the
“workhorse” for the analysis of DCE data [37], the mixed
logit (MXL) and the generalized multinomial logit
(GMNL) model. The MXL model accounts for unob-
served preference (taste) heterogeneity [38] and GMNL
model accounts for both preference and scale heterogen-
eity [39], while relaxing the assumptions of the condi-
tional logit model. A number of different models were
fitted in the GMNL framework. Additional notes are
provided in the Additional file 2.
Akaike information criterion (AIC) was used to assess
the statistical fit of the models. Lower AIC values indi-
cate better fit. Combining the criteria of 1) better
statistical fit with 2) the possibility of accounting for
different types of heterogeneity (taste and/or scale
heterogeneity), would lead to using the results of the
most appropriate model.
Simple descriptive statistics were generated for the
demographic variables.
All the analyses were conducted in STATA statistical
package (version 14SE). The clogit procedure was used
for the conditional logit model, the mixlogit com-
mand [40] was used for the MXL model and the
GMNL model was operationalized with the use of the
gmnl command [41].
Relative impact of attributes
In order to examine which attribute/outcome was the
most significant for the respondents the partial log-
likelihood method was used [42]. The analysis was con-
ducted by systematically re-estimating the models after
dropping from the estimation one attribute at a time,
and noting the respective log-likelihood value of the
model. The partial effect on the log-likelihood i.e. the
difference between the log-likelihood of the model with
all the predictors and that of the model with one omit-
ted variable, was used to order the attributes by their im-
pact. In other words, the attribute with the largest
partial effect-change in log-likelihood, is considered the
most important one compared to the other attributes in-
cluded in the DCE. The result of this analysis would feed
directly into the decision for choosing the primary out-
come for the trial design.
Results
Sample characteristics
The sample characteristics are presented in.
Table 2. A total of 100 respondents were recruited
across the UK. There was an equal gender representa-
tion in the sample. The mean age of the respondents
was 57 years and the majority (41%) belonged to the E
category of the social grade classification i.e. state pen-
sioners, casual and lowest grade workers or unemployed
with state benefits.
Models results
Table 3 presents the results from the CLOGIT and MXL
models. None of the models fitted in the GMNL frame-
work were significant, based on the Wald test, hence the
results are not included here. Additional file 3 provides
more details on the results of different models. The
goodness-of-fit measures (Table 4) demonstrated little
difference between the CLOGIT and MXL model, with
slight advantage for MXL. This probably is indicative of
the fact that the preference heterogeneity that would be
captured by the MXL does not impact hugely on the
overall results.
The coefficients in Table 3 indicate the relative im-
portance, or the utility increase, of moving from the
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reference state to the particular level of the attribute. In
both models, significant coefficients and their positive
signs denote a preference of the respondents for the par-
ticular state versus the reference state, which is always
the extremely bad state. Hence, respondents prefer good
states rather than bad states, which is natural and intui-
tive. When the coefficients are non-significant (as de-
noted by the p-values), there is no evidence of explicit
preference of the respondents for one state/schedule ver-
sus the reference state. This is strongly highlighted in
the case of the health and fitness intervention for gait re-
habilitation where the respondents are indifferent to-
wards different combinations of the frequency of the
intervention (once a week for 12 weeks or twice a week
for 6 weeks) and the nature of the intervention (one-to-
one or group intervention). This is observed in both
models results.
For the attributes pain and daily activities, respondents
attach greater importance to achieving the best health
states compared to moderately impaired states. This is
denoted by the fact that the coefficients are larger for
the perfect health state vs the reference health state,
compared to the moderately impaired health states vs
the reference health state. This is not the case, however,
for the attributes mobility, fatigue and choice of shoes.
For these attributes, the magnitude of the coefficients in-
dicate that respondents attach greater importance to
moving from the extremely impaired state to the mildly
impaired state than to moving from the extremely im-
paired state to the perfect state. For example, in the
conditional logit model results, the coefficient (i.e. the
utility increase) for “I have no problems with mobility” is
smaller than that for “I have some problems with mobil-
ity” (0.176 vs 0.350).
The results from both models are broadly comparable
with respect to the signs and significance of the coeffi-
cients (Table 3). The only difference is for the preference
on the state describing no problems with mobility versus
the reference state which is having extreme problems
with mobility. This is not significant in the mixed logit
model. For the mixed logit model, the significance of the
standard deviation around the mean values of the coeffi-
cients signifies the existence of unobserved preference
heterogeneity in the data. Preference heterogeneity exists
in the choice for most of the “perfect” health states ver-
sus the extremely bad states (e.g. “My feet are not pain-
ful when I walk” compared to “My feet are extremely
painful when I walk”). This is not the case for the mod-
erate states versus the extremely bad states. The non-
significance of the standard deviations may be an indica-
tion of low heterogeneity of preferences among respon-
dents for the specific attribute levels.
The results of the analysis on the relative impact of
the attributes are presented.
Table 5. The outcomes are listed by decreasing order
of impact on the overall log likelihood of the model.
This can be interpreted as the attributes higher up in the
list being the most important. The results demonstrated
that moving from extreme pain to no pain was the most
significant outcome for both models; it accounts for 27%
of the log-likelihood, or 49% for both levels in the CLO-
GIT model.
Discussion and conclusions
This study is one of the first to demonstrate the use of
DCE for establishing preferences of people with RA for
different outcomes and schedule of a health care inter-
vention intended for gait rehabilitation. The results from
this DCE were used as a guide for the design of a RCT,
where the most highly valued outcome from this exer-
cise would inform the choice of the primary outcome in
the trial. In this instance, patients weighted foot and
ankle pain as the most important outcome, with mobility
being nearly as important, and measures of these should
be either the primary outcome of the trial or a key sec-
ondary outcome. This approach is ensuring the patient
involvement at early stages of health care design, evalu-
ation and decision making.
One hundred people with RA completed the DCE and
the results indicate that people value mostly the reduc-
tion in pain. This result was consistent across different
econometric models used for analysing the DCE data,
which is reassuring that the findings of this analysis are
robust and reliable. Different econometric models were
Table 2 Demographic characteristics
Total sample N = 100
Gender (%females) 51
Mean (SD) age in years 57
(12.3)
Age groups (%)
18–24 0
25–34 3
35–44 14
45–54 20
55–64 34
65+ 29
Social grade (%)
A - Higher managerial, administrative and professional 7
B - Intermediate managerial, administrative and professional 18
C1 - Supervisory, clerical and junior managerial,
administrative and professional
11
C2 - Skilled manual workers 15
D - Semi-skilled and unskilled manual workers 8
E - State pensioners, casual and lowest grade workers,
unemployed with state benefits only
41
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used to relax restrictive assumptions on the properties
of the discrete choice data, and take into account scale
or preference heterogeneity. From the analysis, there did
not appear to be sufficient evidence of scale heterogen-
eity or large preference heterogeneity. If large preference
heterogeneity exists, then this has implications for the
policy decisions. For example, the treatment schedule
could be more flexible, to cater for the range of prefer-
ences expressed.
Table 3 Results of conditional logit and mixed logit analysis
Variable (name used in the model) Conditional logit model Mixed logit model
Coefficient (SE) Coefficient (SE)
My feet are somewhat painful when I walk (pain_1) 0.389 (0.069)*** 0.474 (0.082)***
My feet are not painful when I walk (pain_2) 0.44 (0.069)*** 0.536 (0.12)***
I have some problems with mobility (mobility_1) 0.350 (0.069)*** 0.443 (0.079)***
I have no problems with mobility (mobility_2) 0.176 (0.069)* 0.139 (0.117)
I have some problems with doing everyday
activities (daily_activities_1)
0.195 (0.069)** 0.264 (0.08)***
I have no problems with doing everyday
activities (daily_activities_2)
0.27 (0.068)*** 0.396 (0.098)***
I usually feel moderately tired after walking (fatigue_1) 0.167 (0.069)* 0.235 (0.079)**
I usually do not feel tired after walking (fatigue_2) 0.045 (0.068) 0.052 (0.081)
My walking ability is moderately affected by the
footwear I choose (shoes_1)
0.161 (0.069)* 0.223 (0.079)**
My walking ability is not affected by the footwear I choose (shoes_2) 0.104 (0.069) 0.129 (0.092)
To improve my walking, I will go for supervised
exercise as part of a group twice a week for 6 weeks (health_fitness_1)
−0.027 (0.085) −0.057 (0.102)
To improve my walking, I will go for one-to-one
supervised exercise, once a week for 12 weeks (health_fitness_2)
0.124 (0.084) 0.149 (0.099)
To improve my walking, I will go for one-to-one
supervised exercise, twice a week for 6 weeks (health_fitness_3)
0.131 (0.084) 0.173 (0.097)
Standard deviations
pain_1 −0.231 (0.147)
pain_2 0.989 (0.121)***
mobility_1 0.003 (0.196)
mobility_2 0.924 (0.119)***
daily_activities_1 0.123 (0.136)
daily_activities_2 0.626 (0.11)***
fatigue_1 0.004 (0.138)
fatigue_2 −0.198 (0.141)
shoes_1 0.043 (0.098)
shoes_2 −0.481 (0.098)***
health_fitness_1 0.314 (0.158)*
health_fitness_2 −0.23 (0.194)
health_fitness_3 −0.010 (0.174)
Number of observations 3600 3600
chi-squared 108.661 119.858
Model degrees of freedom 13 13
* p < 0.05, ** p < 0.01, *** p < 0.001
Table 4 Goodness-of-fit of the two models
Measure Conditional logit model Mixed logit model
Log likelihood −1193.335 −1133.406
AIC 2412.669 2318.811
BIC 2493.122 2479.717
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Nevertheless, the results demonstrated that the people
with RA have no explicit preference for the different
health and fitness intervention schedules: there was no
preference between attending the exercises on a one-to-
one or group basis, and similarly on the frequency of the
sessions. For the design of the RCT, this is an important
aspect as other elements such as the cost of each sched-
ule or the availability of the practitioners in the different
sites might drive the choice of the service design. In
terms of the outcomes, the respondents preferred good
states rather than bad states, which is an expected and
intuitive response.
For a set of three attributes, mobility, fatigue and
choice of shoes, participants appear to gain larger utility
from mildly impaired states (vs. reference state) than
from perfect states (vs. reference state). This is denoted
by the magnitude of the coefficients in both models. The
findings in this case appear counter-intuitive as one
would expect the opposite. However, a number of rea-
sons might lie behind these results. Firstly, the adapta-
tion effect, where people are used to living in an
impaired state, might play a role in the respondents’ de-
cision making process. Secondly, a pragmatic approach
of the respondents that live daily with RA is probably
evident here in the sense that they are aware of and
complacent with the idea that no intervention will ever
make their health state a perfect one, due to the nature
of the disease itself. Thirdly, there might have been an
overlap in the interpretation of certain attributes. For ex-
ample, for as long one can perform their daily activities,
the level of mobility is not of concern to them. Again,
the adaptation effect, where people can perform their
daily activities despite low levels of mobility. Addition-
ally, the counter-intuitive results might be indeed a con-
sequence of other study limitations.
One of the study limitations relates to the fact that the
experimental design and the model fitting assumed only
main effects; possible interaction effects were not taken
into account. This might not fully reflect the clinical
reality as for example, one could argue than the level of
pain and the ability to do daily activities would have an
inverse relationship. However, the decision to include
only main effects in the DCE design was made to avoid
an overly long and burdensome questionnaire for the re-
spondent which would have resulted from the inclusion
of the interaction effects.
Responses for this study were collected by using an
internet panel. Under ideal conditions, with no time or
Table 5 Hierarchical importance of attributes based on partial log-likelihood analysis
Conditional logit model Mixed logit model
Attribute level
excluded from the
analysis
(by order of impact)
Log
likelihood
Partial effect-
change in log
likelihood
Relative effect - %sum
of change in log
likelihood
Attribute level
excluded from the
analysis
(by order of
impact)
Log
likelihood
Partial effect-
change in log
likelihood
Relative effect -%
sum of change in
log-likelihood
None −1193.335 None −1133.406
Pain_2 −1213.810 −20.475 0.276 Pain_2 −1190.501 −57.095 0.264
Pain_1 −1209.571 −16.236 0.219 Mobility_2 −1167.962 −34.556 0.160
Mobility_1 −1206.337 −13.002 0.175 DActivities_2 −1157.175 −23.769 0.110
DActivities_2 −1201.174 −7.839 0.106 Pain_1 −1156.766 −23.360 0.108
DActivities_1 −1197.358 −4.023 0.054 Mobility_1 −1155.712 −22.306 0.103
Fatigue_1 −1196.652 −3.317 0.045 DActivities_1 −1146.207 −12.801 0.059
Mobility_2 −1196.297 −2.962 0.040 Fatigue_1 −1144.621 −11.215 0.052
Shoes_1 −1196.081 −2.746 0.037 Shoes_1 −1144.179 −10.773 0.050
HF_3 −1194.546 −1.211 0.016 Shoes_2 −1142.456 −9.050 0.042
HF_2 −1194.473 −1.138 0.015 HF_1 −1138.126 −4.720 0.022
Shoes_2 −1194.413 −1.078 0.015 Fatigue_2 −1137.004 −3.598 0.017
Fatigue_2 −1193.553 −0.218 0.003 HF_2 −1135.117 −1.711 0.008
HF_1 −1193.386 −0.051 0.001 HF_3 −1134.987 −1.581 0.007
Notes:
_1 refer to “moderate” states
_2 refer to “perfect” or “no problems” states
Coefficients calculated based on the “extremely bad” state being the baseline
HF_1: ‘To improve my walking, I will go for supervised exercise as part of a group twice a week for 6 weeks’
HF_2: ‘To improve my walking, I will go for one-to-one supervised exercise, once a week for 12 weeks’
HF_3: ‘To improve my walking, I will go for one-to-one supervised exercise, twice a week for 6 weeks’;
Baseline is: ‘To improve my walking, I will go for supervised exercise as part of a group once a week for 12 weeks’
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budget constraint, the survey would have taken place on
a face-to-face basis between the researcher and the re-
spondents. By using an internet panel, there is an elem-
ent of the respondents not fully understanding the task
or rushing through the completion of it. The time re-
spondents took to answer the questions, and the impact
this had on the results is part of a separate study/publi-
cation. The sample size could potentially be considered
another limitation of the study. Although having a sam-
ple size of 100 is considered satisfactory for this type of
survey, a larger sample size might have revealed scale
heterogeneity or larger preference heterogeneity.
A number of studies have assessed patients’ prefer-
ences in RA, ranging from variability in treatment pref-
erences between racial groups [43], preferences for
treatments with varying risk profiles by treatment [44]
and preference for RA treatments based on the route of
administration, the benefits and side effects [45]. The
approach in this study is different and, to our know-
ledge, has not been applied before. This study has dem-
onstrated that it is possible to include patients’
preferences at the RCT design stage to enable better def-
inition of the treatment plan and to identify the primary
outcome. We recommend that where there is uncer-
tainty in either or both the treatment pathways and out-
comes a DCE is undertaken before the RCT design is
completed.
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